These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

948 related items for PubMed ID: 25101575

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Retrospective Multicenter Comparison of S.M.A.R.T. CONTROL and MISAGO Stents in Treatment of Femoropopliteal Lesions.
    Suzuki K, Takahara M, Shintani Y, Tanaka A, Soga Y, Yamaoka T, Tosaka A, Sasaki S, Kawasaki D, Tsuchiya T, Kozuki A, Iida O.
    J Vasc Interv Radiol; 2016 Nov; 27(11):1642-1649. PubMed ID: 27567999
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. PEACE I all-comers registry: patency evaluation after implantation of the 4-French Pulsar-18 self-expanding nitinol stent in femoropopliteal lesions.
    Lichtenberg M, Kolks O, Hailer B, Stahlhoff WF, Tiefenbacher C, Nolte-Ernsting C, Arjumand J, Wittenberg G.
    J Endovasc Ther; 2014 Jun; 21(3):373-80. PubMed ID: 24915584
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Shared and differential factors influencing restenosis following endovascular therapy between TASC (Trans-Atlantic Inter-Society Consensus) II class A to C and D lesions in the femoropopliteal artery.
    Iida O, Takahara M, Soga Y, Suzuki K, Hirano K, Kawasaki D, Shintani Y, Suematsu N, Yamaoka T, Nanto S, Uematsu M.
    JACC Cardiovasc Interv; 2014 Jul; 7(7):792-8. PubMed ID: 25060024
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. First-in-man experience of self-expanding nitinol stents combined with drug-coated balloon in the treatment of femoropopliteal occlusive disease.
    Mwipatayi BP, Perera K, Daneshmand A, Daniel R, Wong J, Thomas SD, Burrows SA.
    Vascular; 2018 Feb; 26(1):3-11. PubMed ID: 28436316
    [Abstract] [Full Text] [Related]

  • 11. Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease.
    Tran K, Ullery BW, Kret MR, Lee JT.
    Ann Vasc Surg; 2017 Jan; 38():90-98. PubMed ID: 27554688
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical outcomes of balloon angioplasty alone versus nitinol stent implantation in patients with small femoropopliteal artery disease: Observations from the Retrospective Multicenter Analysis for Femoropopliteal Stenting (REAL-FP).
    Kamioka N, Soga Y, Kuramitsu S, Iida O, Hirano K, Suzuki K, Kawasaki D, Yamaoka T, Suematsu N, Shintani Y, Miyashita Y, Takahashi H, Tsuchiya T, Shinozaki N, Okazaki S, Ando K.
    Catheter Cardiovasc Interv; 2017 Nov 01; 90(5):790-797. PubMed ID: 28722294
    [Abstract] [Full Text] [Related]

  • 15. Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease.
    Chan YC, Cheng SW, Cheung GC.
    J Vasc Surg; 2015 Nov 01; 62(5):1201-9. PubMed ID: 26169015
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The number of patent tibial vessels does not influence primary patency after nitinol stenting of the femoral and popliteal arteries.
    Lee JJ, Katz SG.
    J Vasc Surg; 2012 Apr 01; 55(4):994-1000; discussion 1000. PubMed ID: 22244857
    [Abstract] [Full Text] [Related]

  • 18. Incidence and the clinical impact of stent fractures after primary stenting for TASC C and D femoropopliteal lesions at 1 year.
    Davaine JM, Quérat J, Guyomarch B, Brennan MÁ, Costargent A, Chaillou P, Patra P, Gouëffic Y.
    Eur J Vasc Endovasc Surg; 2013 Aug 01; 46(2):201-12. PubMed ID: 23773773
    [Abstract] [Full Text] [Related]

  • 19. Clinical outcomes of endovascular treatment of TASC-II C and D femoropopliteal lesions with the Viabahn endoprosthesis.
    Mohr PJ, Oyama JK, Luu JT, Stinis CT.
    Cardiovasc Revasc Med; 2015 Dec 01; 16(8):465-8. PubMed ID: 26483319
    [Abstract] [Full Text] [Related]

  • 20. Long-term outcomes and risk stratification of patency following nitinol stenting in the femoropopliteal segment: retrospective multicenter analysis.
    Iida O, Soga Y, Hirano K, Suzuki K, Yokoi H, Nobuyoshi M, Muramatsu T, Inoue N, Nanto S, Uematsu M.
    J Endovasc Ther; 2011 Dec 01; 18(6):753-61. PubMed ID: 22149222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.